(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.



Fig. 5. CAP350 does not affect RXR{alpha} or TR{alpha} subcellular localization. Representative images of NIH3T3 cells transfected with an expression vector for RXR{alpha} alone (A-C) or TR{alpha} alone (J-L) or cotransfected with expression vectors for RXR{alpha} and CAP350 (D-F) or TR{alpha} and CAP350 (M-O), and analyzed by indirect immunofluoresence microscopy with anti-RXR{alpha} antibody or anti-TR{alpha} antibody (green) and anti-c-Myc antibody (red) to detect tagged CAP350. The merged images indicate that CAP350 does not alter the subcellular localization of RXR{alpha} or TR{alpha} (F and O, respectively). Nuclei were detected by staining with Hoechst (B and K). (G-I) PPAR{alpha} ligand does not affect the subcellular relocalization of PPAR{alpha} in the presence of CAP350. NIH3T3 cells were transfected with expression vectors for PPAR{alpha} and CAP350 in the presence of the PPAR{alpha} ligand Panagonist B and subjected to immunostaining with anti-PPAR{alpha} antibody (green) and anti-c-Myc antibody (red) to detect tagged CAP350. The merged image (I) shows that ligand does not alter the colocalization of PPAR{alpha} and CAP350. Bars, 10 µm.